Graham Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Graham Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,713	Closed	-$256K	–	1577
2024 Q4	$256K	Buy	20,713 +10,012	+94%	+$115K	﹤0.01%	988
2024 Q3	$122K	Buy	+10,701	New	+$107K	﹤0.01%	988
2024 Q2	–	Sell	-11,228	Closed	-$75.2K	–	1436
2024 Q1	$75.2K	Sell	11,228 -4,014	-26%	-$27.6K	﹤0.01%	994
2023 Q4	$99.1K	Buy	+15,242	New	+$98.2K	﹤0.01%	909

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Graham Capital Management's CDMO Position: Q1 2025 in Review

Graham Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 20,713 shares — an estimated $256K sold.

Graham Capital Management first reported a position in CDMO in Q4 2023 and held it in 4 quarters. The position peaked at $256K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Graham Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Graham Capital Management sold 20,713 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $256K.
Graham Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 4 quarters.
Graham Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $256K in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Graham Capital Management's 13F filing for Q1 2025, filed 15 May 2025.